An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing

Journal: Nature Communications

Published: 2021-03-19

DOI: 10.1038/s41467-021-21996-6

Affiliations: 7

Authors: 14

Go to article
Institutions Share
Nanyang Technological University (NTU), Singapore 0.49
Genome Institute of Singapore (GIS), A*STAR, Singapore 0.23
National University Health System (NUHS), Singapore 0.21
Bioinformatics Institute (BII), A*STAR, Singapore 0.07